A Phase 1 first-in-human study of MEDI0680, an anti-PD-1 monoclonal antibody (mAb) in adult patients (pts) with advanced tumors
Naing, A., Goel, S., Curti, B., Weise, A., Eder, J.P., Marshall, S., Morehouse, C., Li, X., Karakunnel, J.J., Infante, J.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw378.26
Date:
October, 2016
File:
PDF, 42 KB
english, 2016